Literature DB >> 1280113

Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction.

R G Maatman1, E M van de Westerlo, T H van Kuppevelt, J H Veerkamp.   

Abstract

The cDNAs of two types of fatty acid-binding protein (FABP) present in human kidney, previously described as types A and B, were isolated using reverse transcriptase-PCR (RT-PCR) with human kidney mRNA and various sets of primers. The cDNA fragments were cloned and sequenced. Renal FABP type A and B cDNAs appeared to be completely identical to human liver- and heart-type FABP cDNAs respectively. In the second part of this study we demonstrated the presence of liver-type FABP in rat kidney by chromatography, e.l.i.s.a. and immunocytochemistry. The ratio and cellular distribution of the two FABP types varies markedly in human and rat kidney. Using RT-PCR we were also able to prepare and identify liver- and heart-type FABP cDNAs with mRNA from both male and female rat kidney.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280113      PMCID: PMC1132111          DOI: 10.1042/bj2880285

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  Structural and functional features of different types of cytoplasmic fatty acid-binding proteins.

Authors:  J H Veerkamp; R A Peeters; R G Maatman
Journal:  Biochim Biophys Acta       Date:  1991-01-04

2.  Renal reabsorption of low molecular weight proteins in adult male rats: alpha 2u-globulin.

Authors:  O W Neuhaus
Journal:  Proc Soc Exp Biol Med       Date:  1986-09

3.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Kidney fatty acid-binding protein: identification as alpha 2U-globulin.

Authors:  H Kimura; S Odani; J Suzuki; M Arakawa; T Ono
Journal:  FEBS Lett       Date:  1989-03-27       Impact factor: 4.124

5.  Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes.

Authors:  D A Sweetser; E H Birkenmeier; P C Hoppe; D W McKeel; J I Gordon
Journal:  Genes Dev       Date:  1988-10       Impact factor: 11.361

6.  Primary structure and cellular distribution of two fatty acid-binding proteins in adult rat kidneys.

Authors:  H Kimura; S Odani; S Nishi; H Sato; M Arakawa; T Ono
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

7.  Immunochemical quantitation of fatty acid-binding proteins. Tissue distribution of liver and heart FABP types in human and porcine tissues.

Authors:  R J Paulussen; H T van Moerkerk; J H Veerkamp
Journal:  Int J Biochem       Date:  1990

8.  Characterization of a cloned cDNA encoding rabbit myelin P2 protein.

Authors:  V Narayanan; E Barbosa; R Reed; G Tennekoon
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

9.  Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA.

Authors:  C A Baxa; R S Sha; M K Buelt; A J Smith; V Matarese; L L Chinander; K L Boundy; D A Bernlohr
Journal:  Biochemistry       Date:  1989-10-31       Impact factor: 3.162

10.  Ontogenic appearance of three fatty acid binding proteins in the rat stomach.

Authors:  S Iseki; T Kanda; M Hitomi; T Ono
Journal:  Anat Rec       Date:  1991-01
View more
  43 in total

1.  Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells.

Authors:  F Schroeder; B P Atshaves; O Starodub; A L Boedeker; R R Smith; J B Roths; W B Foxworth; A B Kier
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.

Authors:  Weibin Qian; Junichi Hasegawa; Satoshi Tsuno; Yusuke Endo; Akiko Matsuda; Norimasa Miura
Journal:  Yonago Acta Med       Date:  2014-12-26       Impact factor: 1.641

3.  Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals.

Authors:  Keisei Kosaki; Atsuko Kamijo-Ikemori; Takeshi Sugaya; Koichiro Tanahashi; Hiroshi Kumagai; Yuriko Sawano; Nobuhiko Akazawa; Song-Gyu Ra; Kenjiro Kimura; Yugo Shibagaki; Seiji Maeda
Journal:  Clin Exp Nephrol       Date:  2017-02-14       Impact factor: 2.801

Review 4.  Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application.

Authors:  Zubaida Al-Ismaili; Ana Palijan; Michael Zappitelli
Journal:  Pediatr Nephrol       Date:  2010-07-10       Impact factor: 3.714

5.  Emerging urinary biomarkers in the diagnosis of acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Expert Opin Med Diagn       Date:  2008-04

6.  Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis.

Authors:  Paweena Susantitaphong; Monchai Siribamrungwong; Kent Doi; Eisei Noiri; Norma Terrin; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2012-12-08       Impact factor: 8.860

7.  Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients.

Authors:  Stine Elkjaer Nielsen; Takeshi Sugaya; Peter Hovind; Tsuneharu Baba; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

8.  The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.

Authors:  Gregory G Martin; Avery L McIntosh; Huan Huang; Shipra Gupta; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2013-12-10       Impact factor: 3.162

Review 9.  Biomarkers of nephrotoxic acute kidney injury.

Authors:  Michael A Ferguson; Vishal S Vaidya; Joseph V Bonventre
Journal:  Toxicology       Date:  2008-01-04       Impact factor: 4.221

10.  Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

Authors:  Stine E Nielsen; Takeshi Sugaya; Lise Tarnow; Maria Lajer; Katrine J Schjoedt; Anne Sofie Astrup; Tsuneharu Baba; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.